GNPX
GNPX
NASDAQ · Biotechnology

Genprex Inc

$1.76
-0.01 (-0.57%)
As of Mar 31, 4:55 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,471.6% upside
Low Target $20.34
Average Target $27.66
High Target $35.38
Current Price $1.76
Current
$1.76
Target
$27.66
$20.34 $27.66 avg $35.38
Scenario Analysis
Bear Case
$20.34
1,055.7%
Low target
Base Case
$27.66
+1,471.6%
Avg target
Bull Case
$35.38
+1,910.2%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$55.00
-96.8% from high
52-Week Low
$1.71
+2.9% from low
Target vs 52W High
$27.66
-49.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +18.4%
AMGN
Amgen Inc
Hold 42 50% $190.87 -45.8%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +160.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -1.8%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.1%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -28.5%